跳至主要内容
临床试验/TCTR20210607002
TCTR20210607002尚未招募4 期

A Randomized Controlled Trial: Efficacy of Dexamethasone Versus Methylprednisolone Intratympanic Injection for Primary Treatment of Idiopathic Sudden Sensorineural Hearing Loss

Faculty of Medicine, Chulalongkorn University0 个研究点目标入组 56 人开始时间: 2021年6月7日最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
入组人数
56

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
All

入选标准

  • 1. New patient age 18-80 years old with diagnosed as sensorineural hearing loss which decrease in hearing of 30 or more decibels affecting at least 3 consecutive frequencies and occurs within a 72-hour window
  • 2. Only affects in one ear
  • 3. No previous corticosteroids
  • 4. Presents within 2 weeks of symptom onset

排除标准

  • 1. Known cause of hearing loss
  • 2. Fluctuated hearing level or history of previous hearing loss

研究者

相似试验